BOSTON & SCCT ANNUAL MEETING, MONTREAL--(BUSINESS WIRE)--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has made two additions to its Board of Directors. The company named Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH as board directors.
The appointments will help guide Elucid as it accelerates its clinical research strategy, commercializes its flagship PlaqueIQ coro